4
Changes in Ownership
Amphastar Pharmaceuticals, Inc. Filed Acc 0001104659-24-003050
COO,Chief Scientist & Chairman sold 219,800 shares at an average $58.23 ($12,798,708)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Luo Mary Z. COO,Chief Scientist & Chairman | 2024-01-08 | Sale 10b5-1 | −18,858 | $56.98 | $1,074,563 | 1,436,744 | D |
| Luo Mary Z. COO,Chief Scientist & Chairman | 2024-01-08 | Sale 10b5-1 | −41,282 | $58.25 | $2,404,474 | 1,395,462 | D |
| Luo Mary Z. COO,Chief Scientist & Chairman | 2024-01-08 | Sale 10b5-1 | −37,865 | $59.24 | $2,243,142 | 1,357,597 | D |
| Luo Mary Z. COO,Chief Scientist & Chairman | 2024-01-08 | Sale 10b5-1 | −27,563 | $59.99 | $1,653,623 | 1,330,034 | D |
| Luo Mary Z. COO,Chief Scientist & Chairman | 2024-01-08 | Sale 10b5-1 | −4,261 | $61.19 | $260,742 | 1,325,773 | D |
| Luo Mary Z. COO,Chief Scientist & Chairman | 2024-01-08 | Sale 10b5-1 | −1,663 | $61.81 | $102,784 | 1,324,110 | D |
| Luo Mary Z. COO,Chief Scientist & Chairman | 2024-01-08 | Sale 10b5-1 | −2,152 | $63.27 | $136,149 | 1,321,958 | D |
| Luo Mary Z. COO,Chief Scientist & Chairman | 2024-01-09 | Sale 10b5-1 | −50,678 | $56.70 | $2,873,640 | 1,271,280 | D |
| Luo Mary Z. COO,Chief Scientist & Chairman | 2024-01-09 | Sale 10b5-1 | −31,764 | $57.70 | $1,832,872 | 1,239,516 | D |
| Luo Mary Z. COO,Chief Scientist & Chairman | 2024-01-09 | Sale 10b5-1 | −3,714 | $58.35 | $216,720 | 1,235,802 | D |
| Open-market sales · 219,800 sh · avg $58.23 · $12,798,708 | |||||||
Loading xslF345X05/tm241836-2_4seq1.xml…